The development of a faecal incontinence core outcome set: an international Delphi study protocol.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Mar 2021
Historique:
accepted: 26 01 2021
pubmed: 4 2 2021
medline: 24 6 2021
entrez: 3 2 2021
Statut: ppublish

Résumé

Faecal incontinence (FI) is estimated to affect around 7.7% of people. There is a lack of uniformity in outcome definitions, measurement and reporting in FI studies. Until now, there is no general consensus on which outcomes should be assessed and reported in FI research. This complicates comparison between studies and evidence synthesis, potentially leading to recommendations not evidence-based enough to guide physicians in selecting an FI therapy. A solution for this lack of uniformity in reporting of outcomes is the development of a Core Outcome Set (COS) for FI. This paper describes the protocol for the development of a European COS for FI. Patient interviews and a systematic review of the literature will be performed to identify patient-, physician- and researcher-oriented outcomes. The outcomes will be categorised using the COMET taxonomy and put forward to a group of patients, physicians (i.e. colorectal surgeons, gastroenterologists and general practitioners) and researchers in a Delphi consensus exercise. This exercise will consist of up to three web-based rounds in which participants will prioritise and condense the list of outcomes, which is expected to result in consensus. A consensus meeting with participants from all stakeholder groups will take place to reach a final agreement on the COS. This study protocol describes the development of a European COS to improve reliability and consistency of outcome reporting in FI studies, thereby improving evidence synthesis and patient care. This project has been registered in the COMET database on the 1st of April 2020, available at http://www.comet-initiative.org/Studies/Details/1554 . The systematic review has been registered on the PROSPERO database on the 31st of August 2020, available at https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=202020&VersionID=1381336 .

Identifiants

pubmed: 33532899
doi: 10.1007/s00384-021-03865-2
pii: 10.1007/s00384-021-03865-2
pmc: PMC7895769
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-622

Références

PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Colorectal Dis. 2014 Mar;16(3):156-8
pubmed: 24450821
Trials. 2016 Sep 13;17(1):449
pubmed: 27618914
Cochrane Database Syst Rev. 2013 Jun 11;(6):CD002116
pubmed: 23757096
J Clin Gastroenterol. 2014 Oct;48(9):752-64
pubmed: 25014235
Dis Colon Rectum. 2015 Dec;58(12):1194-209
pubmed: 26544818
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
Am J Gastroenterol. 2015 Jan;110(1):138-46; quiz 147
pubmed: 25331348
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
J Wound Ostomy Continence Nurs. 2012 Jan-Feb;39(1):61-74
pubmed: 22193141
J Clin Epidemiol. 2018 Apr;96:84-92
pubmed: 29288712
World J Gastroenterol. 2017 Jan 7;23(1):11-24
pubmed: 28104977
Colorectal Dis. 2009 Nov;11(9):927-32
pubmed: 19175656
Trials. 2012 Aug 06;13:132
pubmed: 22867278
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
Gastroenterology. 2016 Mar 25;:
pubmed: 27144630
Skeletal Radiol. 2011 Aug;40(8):959-61
pubmed: 21667147
World J Gastroenterol. 2009 Jul 14;15(26):3276-82
pubmed: 19598304
Neurogastroenterol Motil. 2016 Aug;28(8):1123-33
pubmed: 27440495
BMJ. 2010 Feb 15;340:c365
pubmed: 20156912

Auteurs

Sadé Assmann (S)

Department of Surgery and Colorectal Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands. s.assmann@maastrichtuniversity.nl.
Division of Gastroenterology-Hepatology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands. s.assmann@maastrichtuniversity.nl.
School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands. s.assmann@maastrichtuniversity.nl.

Daniel Keszthelyi (D)

Division of Gastroenterology-Hepatology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.

Jos Kleijnen (J)

School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands.

Merel Kimman (M)

Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands.

Foteini Anastasiou (F)

4rth TOMY - Academic Primary Care Unit Clinic of Social and Family Medicine, University of Crete, Heraklion, Greece.

Elissa Bradshaw (E)

Community Gastroenterology Specialist Nurse, Royal Free Hospital, London, England.

Emma Carrington (E)

Surgical Professorial Unit, Department of Colorectal Surgery, St Vincent's University Hospital, Dublin, Ireland.

Giuseppe Chiarioni (G)

Division of Gastroenterology of the University of Verona, AOUI Verona, Verona, Italy.
Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Yasuko Maeda (Y)

Department of Surgery and Colorectal Surgery, Western General Hospital, Edinburgh, UK.

Jean Muris (J)

Department of General Practice, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Daniel Pohl (D)

Department of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland.

Mona Rydningen (M)

Department of Gastrointestinal Surgery, University Hospital of North Norway, Tromsø, Norway.
Norwegian National Advisory Unit on Incontinence and Pelvic Floor Health, Tromsø, Norway.

Carolynne Vaizey (C)

St Mark's Hospital, The National Bowel Hospital, London, UK.

Stephanie Breukink (S)

Department of Surgery and Colorectal Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH